|
|
|
||||||
|
|
Showing Treatment 1 to 25 of 26 | |
Location | |
Last Updated | |
|
| ||||||||
|
Details | |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) | |
Chicago, IL | |
07/18/2010 | |
|
|
|
||||||
|
Details | |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) | |
Boston, MA | |
03/09/2010 | |
| ||||||||
|
Details | |
Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor | |
Boston, MA | |
09/06/2009 | |
|
|
|
||||||
|
Details | |
Gliogene: An International Brain Tumor Study | |
Houston, TX | |
07/24/2008 | |
| ||||||||
|
Details | |
Phase I/II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults With Recurrent Glioblastoma Multiforme | |
Houston , TX | |
04/27/2008 | |
|
|
|
||||||
|
Details | |
A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas | |
Boston, MA | |
04/15/2008 | |
| ||||||||
|
Details | |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma | |
Cleveland, OH | |
04/11/2008 | |
|
|
|
||||||
|
Details | |
NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma | |
Boston, MA | |
10/03/2007 | |
| ||||||||
|
Details | |
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma | |
Boston, MA | |
08/19/2007 | |
|
|
|
||||||
|
Details | |
A Pilot Multicenter Phase I/II Trial of RAD001 in Patients With Recurrent Glioblastoma Multiforme | |
Boston, MA | |
08/19/2007 | |
| ||||||||
|
Details | |
Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma | |
Boston, MA | |
08/04/2007 | |
|
|
|
||||||
|
Details | |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas | |
Cleveland, OH | |
05/01/2007 | |
| ||||||||
|
Details | |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer | |
Cleveland, OH | |
05/01/2007 | |
|
|
|
||||||
|
Details | |
Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination With Lapatinib in Adult Patients With Relapsed Malignant Glioma | |
Boston, MA | |
05/01/2007 | |
| ||||||||
|
Details | |
PEG-Interferon alfa-2b With or Without Thalidomide in Treating Patients With Recurrent High-Grade Gliomas | |
Boston, MA | |
05/04/2006 | |
|
|
|
||||||
|
Details | |
The use of the Gliasite radiation therapy system for malignant gliomas | |
Mobile , AL | |
12/03/2005 | |
| ||||||||
|
Details | |
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma | |
, | |
11/27/2005 | |
|
|
|
||||||
|
Details | |
A Randomized Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron) Alone or in Combination with Thalidomide in Adults with Recurrent High-Grade Gliomas | |
Boston, MA | |
11/27/2005 | |
| ||||||||
|
Details | |
A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma | |
Chicago, IL | |
11/13/2005 | |
|
|
|
||||||
|
Details | |
Study of Lenalidomide and XRT in Patients with Newly Diagnosed Glioblastoma Multiforme | |
Boston, MA | |
11/09/2005 | |
| ||||||||
|
Details | |
Phase I Study of Tipifarnib and Radiotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma | |
Boston, MA | |
11/06/2005 | |
|
|
|
||||||
|
Details | |
A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy | |
Mobile, AL | |
11/06/2005 | |
| ||||||||
|
Details | |
SWOG (RTOG) 98-13 randomized trial of RT + Temozolomide vs RT + BCNU, versus RT+ Tem + BCNU | |
Mobile , AL | |
11/06/2005 | |
|
|
|
||||||
|
Details | |
Z0300: Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in the Management of Patients with One to Three Cerebral Mets | |
Mobile , AL | |
11/06/2005 | |
| ||||||||
|
Details | |
Radiosurgery with the Varian Trilogy system for benign or malignant brain tumors | |
Mobile , AL | |
11/06/2005 | |
|
|
|
||||||
| ||||||||
Sorry - There were no pages found that contain that search phrase.